why choose us

First received: September 26, 2022

Clinical Trial: Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial (HAPCET): a Single-center Randomized Controlled Trial

Brief Summary: This study is being done to evaluate the safety and effectiveness of combined Hybrid Argon Plasma Coagulation (HAPC) and Endoscopic Sleeve Gastroplasty (ESG) for weight loss and improvement in obesity-related co-morbidities compared to ESG alone in participants with a BMI ? 30 and ?40 kg/m² who have failed to achieve and maintain weight loss with a non-surgical program.

Read more